By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NewLink Genetics 

2901 South Loop Drive
Suite 3900
Ames  Iowa  50010  U.S.A.
Phone: 515-296-5555 Fax: 515-296-5557


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Data From Clinical Study Of NewLink Genetics (NLNK)’ IDO Pathway Inhibitor, Indoximod, To Be Presented At The 22nd European Hematology Association Congress 5/18/2017 9:07:30 AM
NewLink Genetics (NLNK) Reports First Quarter 2017 Financial Results And Updates Clinical Trial Guidance 5/4/2017 8:52:19 AM
NewLink Genetics (NLNK) To Host Its First Quarter 2017 Financial Results Conference Call On May 4, 2017 4/13/2017 9:43:28 AM
NewLink Genetics (NLNK) Release: Interim Phase II Data Demonstrate Robust Response Rate With Indoximod In Combination With Keytruda® (Pembrolizumab) For Patients With Advanced Melanoma At AACR Plenary 4/4/2017 11:01:44 AM
NewLink Genetics (NLNK) Emerges As Biotech's Newest Immuno-Oncology Takeover Target 4/4/2017 7:13:24 AM
NewLink Genetics (NLNK) Provides Operational & Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results 2/28/2017 6:19:11 AM
NewLink Genetics (NLNK) To Host Its Fourth Quarter And Year End 2016 Financial Results Conference Call On February 28, 2017 2/20/2017 8:08:46 AM
NewLink Genetics (NLNK) Provides Operational Update And Reports Third Quarter 2016 Financial Results 11/1/2016 10:52:57 AM
NewLink Genetics (NLNK) Shares Its Immuno-Oncology Strategy 2016 Analyst And Investor Day 10/26/2016 7:46:27 AM
NewLink Genetics (NLNK) To Host Its Third Quarter 2016 Financial Results Conference Call On November 1, 2016 10/24/2016 7:54:37 AM
12345678910...
//-->